James Xue
Amministratore Delegato presso CANBRIDGE PHARMACEUTICALS INC.
Patrimonio netto: 2 M $ in data 30/04/2024
Posizioni attive di James Xue
Società | Posizione | Inizio | Fine |
---|---|---|---|
CANBRIDGE PHARMACEUTICALS INC. | Amministratore Delegato | 30/01/2018 | - |
Presidente | 30/01/2018 | - | |
Fondatore | 30/01/2018 | - | |
CANbridge Life Sciences Ltd.
CANbridge Life Sciences Ltd. Pharmaceuticals: MajorHealth Technology CANbridge Life Sciences Ltd. produces biopharmaceutical products. It engages in the research and development of therapeutic drug treatment for critical medical condition. The company was founded by James Xue on June 12, 2012 and is headquartered in Chaoyang, China. | Amministratore Delegato | 12/06/2012 | - |
Presidente | 12/06/2012 | - | |
Fondatore | 12/06/2012 | - | |
Presidente | 12/06/2012 | - | |
CANbridge Consulting LLC | Fondatore | - | - |
Presidente | - | - | |
Canbridge Pharmaceuticals, Inc. (United States)
Canbridge Pharmaceuticals, Inc. (United States) BiotechnologyHealth Technology Part of CANbridge Pharmaceuticals Inc., Canbridge Pharmaceuticals is a rare disease-focused biopharmaceutical company based in Cambridge, MA. Canbridge Pharmaceuticals, Inc. (United States) was established in 2012 and is committed to researching, developing, and commercializing transformative therapies for rare diseases. | Direttore/Membro del Consiglio | - | - |
Presidente | - | - | |
Segretario Aziendale | - | - | |
China Alliance For Rare Diseases | Corporate Officer/Principal | - | - |
Shanghai Foundation For Rare Disease | Corporate Officer/Principal | - | - |
University of Michigan Medical School | Corporate Officer/Principal | 01/08/2017 | - |
Peking University Health Science Center | Corporate Officer/Principal | 01/08/2017 | - |
The BayHelix Group | Corporate Officer/Principal | - | - |
Storia della carriera di James Xue
Precedenti posizioni note di James Xue
Società | Posizione | Inizio | Fine |
---|---|---|---|
░░░░░░░ ░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
Formazione di James Xue
Peking University School of Pharmaceutical Sciences | Undergraduate Degree |
Brown University | Doctorate Degree |
University of California | Graduate Degree |
University of Virginia Darden School of Business | Masters Business Admin |
Statistiche
Distribuzione geografica
Stati Uniti | 9 |
Cina | 6 |
Isole Cayman | 2 |
Posizioni
Corporate Officer/Principal | 6 |
Founder | 3 |
President | 3 |
Settori
Consumer Services | 7 |
Health Technology | 5 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
CANBRIDGE PHARMACEUTICALS INC. | Health Technology |
Aziende private | 7 |
---|---|
CANbridge Life Sciences Ltd.
CANbridge Life Sciences Ltd. Pharmaceuticals: MajorHealth Technology CANbridge Life Sciences Ltd. produces biopharmaceutical products. It engages in the research and development of therapeutic drug treatment for critical medical condition. The company was founded by James Xue on June 12, 2012 and is headquartered in Chaoyang, China. | Health Technology |
CANbridge Consulting LLC | |
Canbridge Pharmaceuticals, Inc. (United States)
Canbridge Pharmaceuticals, Inc. (United States) BiotechnologyHealth Technology Part of CANbridge Pharmaceuticals Inc., Canbridge Pharmaceuticals is a rare disease-focused biopharmaceutical company based in Cambridge, MA. Canbridge Pharmaceuticals, Inc. (United States) was established in 2012 and is committed to researching, developing, and commercializing transformative therapies for rare diseases. | Health Technology |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
China Alliance For Rare Diseases | |
Shanghai Foundation For Rare Disease | |
The BayHelix Group |
- Borsa valori
- Insiders
- James Xue
- Esperienza